* TRxADE Health Inc MEDS.OQ MEDS.O is expected to show a
fall
in quarterly revenue when it reports results for the period
ending June 30 2023
* The Lutz Florida-based company is expected to report a
5.0% decrease in revenue to $2.28 million from $2.4 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for TRxADE Health Inc is for
a
loss of 15 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for TRxADE
Health Inc
is $6.75, above its last closing price of $6.20.
This summary was machine generated December 8 at 21:02 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)